The 44th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2026)

Bologna, Italy 01 June 2026 - 05 June 2026

Age-based ivermectin dosing safe, efficacious in children with scabies infection

In the treatment of scabies infection in children up to 2 years of age, age-based ivermectin dosing yields high response rates and is well-tolerated, according to the open-label phase 2 ITCHY 2 study.

Age-based ivermectin dosing safe, efficacious in children with scabies infection

15 hours ago

Nirsevimab prevents RSV-related hospitalizations, severe disease in infants

17 hours ago by

Treatment with nirsevimab has been shown to bring down the number of hospitalizations due to respiratory syncytial virus (RSV) infections and prevent the development of severe disease in infants, according to a study presented at ESPID 2026.

Nirsevimab prevents RSV-related hospitalizations, severe disease in infants

17 hours ago

Adjunctive clindamycin reduces mortality in kids with iGAS infections

16 Jun 2026 by

An observational study shows an association between adjunctive clindamycin and reduced odds of mortality in children with invasive Group A streptococcal (iGAS) infections.